Congrats to my three ⭐️’s, for matching to onc fellowships - rachel keogh Johns Hopkins HopkinsHemOncFellowship - #YoungSooRho Dartmouth David Feller-Kopman - ⁦Aanika Balaji⁩ NIH @gulleyj1 Beaumont RCSI Cancer Centre ⁦⁦Johns Hopkins Kimmel Cancer Center⁩

jto.org/article/S1556-… Compelling pre-clinical evidence of MUC1 activation as critical to resistance in osi treated EGFR mutant NSCLC; Could this pathway be implicated in other oncogenic NSCLC? Congratulations to all authors👏✍️ @LCSM IASLC ESMO - Eur. Oncology

Congratulations Rachel J Keogh and Jarushka Naidoo and the whole team on this important project. Thank you for the opportunity to contribute. We will use this data to inform future 🇮🇪 and 🇪🇺 NSCLC trials

mdpi.com/2072-6694/16/3… - All oncogene cancers are not created equal - IO largely uneffective in EGFR/ALK but effective in others (eg KRAS) Congrats to David McMahon Ronan Andrew McLaughlin Jarushka Naidoo on a robust review of a clinically important question #lcsm IASLC

Thanks for sharing and to patients and collaborators! Look forward to sharing results of our larger ongoing study in the hopefully not too distant future EACR News IACR Beaumont RCSI Cancer Centre Jarushka Naidoo Dr Sinead Toomey RCSI_StAR MD

Delighted to see the EMBER 4 study opened by Prof Patrick Morris Beaumont RCSI Cancer Centre A Phase 3 Study of Adjuvant Imlunestrant vs standard adjuvant endocrine therapy in patients who have previously received 2 to 5 years of adjuvant endocrine therapy for ER+ HER2- early breast cancer

Inspiring talk and keynote lecture from ProfJohnCrown with an amazing list of achievements and impact on modern mathematics of HER2 positive breast cancer Thank you! EACR News IACR

Congratulations David McMahon representing 🇮🇪 and The Royal Marsden NHS Foundation Trust

Looking forward to listening in! Hazel O'Sullivan @stephenvliu @myesmo Emma-Louise Curran UCC Cancer Trials Group 🇮🇪

Congratulations Maeve Hennessy, so well deserved 🇮🇪 Roisin Connolly Breakthrough Cancer Research United Custard

Congratulations Ronan Andrew McLaughlin , very well deserved!

Congratulations to all..what a great bunch! David McMahon Ronan Andrew McLaughlin Carolyn Moloney Maeve Hennessy Zac Sarah E. Lochrin

📢The PLAN study, a translational IIT for #LungCancer patients, has reached its accrual target of 138 in record time! Congrats Jarushka Naidoo David O Reilly @GKorpantyDr & everyone at the 4⃣ sites involved! 👏#worldlungcancerday Trinity St James's Cancer Institute @beaconCTRU @ULHospitals

Please to share the results of our work. Thanks to all contributors. More work needed to reduce toxicity for our patients! Beaumont RCSI Cancer Centre Jarushka Naidoo Lizza Hendriks Caroline O'Leary @aislinnreilly Kathleen Bennett Min Yuen Teo 張鳴元

We are thrilled to have 20 participants join the faculty at the 2024 IASLC Reviewer Workshop, organized by IASLC, JTO and JTO CRR on Sep 11 in San Diego. We look forward to many engaging discussions and learning! JTO & JTO CRR #WCLC24 #reviewer

Is there a role for surgery in mesothelioma? - There is a lack of randomised data demonstrating survival improvement - However, patient selection in this rare disease is paramount - Hopefully another RCT will come soon #WCLC2024

Great to get the Irish #LungCancer community together at #WCLC24 Lots of energy looking to shift the dial for patients Jarushka Naidoo Dr Anne-Marie Baird Patrick Forde Dr Martin Barr #IrishLungCancerCommunity Seamus Cotter David O Reilly ☘️